Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
4.050
+0.190 (4.92%)
At close: Dec 20, 2024, 4:00 PM
4.020
-0.030 (-0.74%)
After-hours: Dec 20, 2024, 6:47 PM EST
Metagenomi Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Metagenomi stock have an average target of 16.67, with a low estimate of 6.00 and a high estimate of 25. The average target predicts an increase of 311.60% from the current stock price of 4.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Metagenomi stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +245.68% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +72.84% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +270.37% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +72.84% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +72.84% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
49.94M
from 44.76M
Increased by 11.59%
Revenue Next Year
32.62M
from 49.94M
Decreased by -34.69%
EPS This Year
-2.54
from -20.05
EPS Next Year
-2.70
from -2.54
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 65.1M | 64.1M | 126.2M |
| Avg | 49.9M | 32.6M | 38.6M |
| Low | 34.3M | 9.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 45.5% | 28.2% | 286.9% |
| Avg | 11.6% | -34.7% | 18.3% |
| Low | -23.4% | -80.4% | -70.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.49 | -1.09 | -0.19 |
| Avg | -2.54 | -2.70 | -2.04 |
| Low | -2.60 | -3.52 | -3.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.